Abstract:Background: The CANTOS trial (Canakinumab Antiinflammatory Thrombosis Outcome Study) showed that antagonism of interleukin (IL)–1&bgr; reduces coronary heart disease in patients with a previous myocardial infarction and evidence of systemic inflammation, indicating that pathways required for IL-1&bgr; secretion increase cardiovascular risk. IL-1&bgr; and IL-18 are produced via the NLRP3 inflammasome in myeloid cells in response to cholesterol accumulation, but mechanisms linking NLRP3 inflammasome activation to atherogenesis are unclear. The cholesterol transporters ATP binding cassette A1 and G1 (ABCA1/G1) mediate cholesterol efflux to high-density lipoprotein, and Abca1/g1 deficiency in myeloid cells leads to cholesterol accumulation. Methods: To interrogate mechanisms connecting inflammasome activation with atherogenesis, we used mice with myeloid Abca1/g1 deficiency and concomitant deficiency of the inflammasome components Nlrp3 or Caspase-1/11. Bone marrow from these mice was transplanted into Ldlr −/− recipients, which were fed a Western-type diet. Results: Myeloid Abca1/g1 deficiency increased plasma IL-18 levels in Ldlr −/− mice and induced IL-1&bgr; and IL-18 secretion in splenocytes, which was reversed by Nlrp3 or Caspase-1/11 deficiency, indicating activation of the NLRP3 inflammasome. Nlrp3 or Caspase-1/11 deficiency decreased atherosclerotic lesion size in myeloid Abca1/g1-deficient Ldlr −/− mice. Myeloid Abca1/g1 deficiency enhanced caspase-1 cleavage not only in splenic monocytes and macrophages, but also in neutrophils, and dramatically enhanced neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques, with reversal by Nlrp3 or Caspase-1/11 deficiency, suggesting that inflammasome activation promotes neutrophil recruitment and neutrophil extracellular trap formation in atherosclerotic plaques. These effects appeared to be indirectly mediated by systemic inflammation leading to activation and accumulation of neutrophils in plaques. Myeloid Abca1/g1 deficiency also activated the noncanonical inflammasome, causing increased susceptibility to lipopolysaccharide-induced mortality. Patients with Tangier disease, who carry loss-of-function mutations in ABCA1 and have increased myeloid cholesterol content, showed a marked increase in plasma IL-1&bgr; and IL-18 levels. Conclusions: Cholesterol accumulation in myeloid cells activates the NLRP3 inflammasome, which enhances neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques. Patients with Tangier disease, who have increased myeloid cholesterol content, showed markers of inflammasome activation, suggesting human relevance.

Increased Plasma IgE Accelerate Atherosclerosis in Secreted IgM Deficiency

Atherosclerotic plaque vulnerability is increased in mouse model of lupus

IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation

IgE Actions on CD4+ T Cells, Mast Cells, and Macrophages Participate in the Pathogenesis of Experimental Abdominal Aortic Aneurysms.

Disruption of Phospholipid Transfer Protein-Mediated High-Density Lipoprotein Maturation Reduces Scavenger Receptor BI Deficiency-Driven Atherosclerosis Susceptibility Despite Unexpected Metabolic Complications

Endothelial Cell Injury is Involved in Atherosclerosis and Lupus Symptoms in Gld.apoe- / - Mice.

Abstract 21: B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis

Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice

Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in Mice

Deficiency of Immunoglobulin E Protects Mice from Experimental Abdominal Aortic Aneurysms

Abstract 43: Cholesterol Efflux Pathways Suppress Inflammasome Activation in Mice and Humans

Deficiency in Lymphotoxin β Receptor Protects From Atherosclerosis in apoE-Deficient Mice

Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice

Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis

The E3 Ubiquitin Ligase Peli1 Deficiency Promotes Atherosclerosis Progression

Raising Endogenous Anti-HMGB1 IgM Antibody for Athero-Protection in the Apoe−/− Mouse Model of Atherosclerosis

Allergic Asthma Aggravated Atherosclerosis Increases Cholesterol Biosynthesis and Foam Cell Formation in Apolipoprotein E-deficient Mice.

Chemokine Receptor-6 Promotes B-1 Cell Trafficking to Perivascular Adipose Tissue, Local IgM Production and Atheroprotection

Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis

Deficiency of Cathepsin S Reduces Atherosclerosis in LDL Receptor–deficient Mice